Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 316.50
+4.10 (1.31%)
At close: Sep 16, 2026
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 141.77 billion as of September 16, 2026. Its market cap has increased by 79.35% in one year.
Market Cap
141.77B
Enterprise Value
135.59B
Revenue
31.72B
Ranking
n/a
PE Ratio
27.44
Stock Price
316.50
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 141.77B, an increase of 3,782.51%. That is a compound annual growth rate of 20.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 141.77B | 73.53% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |
| Procter & Gamble Health | 89.81B |
| Bliss GVS Pharma | 76.78B |